Root Operation 0: Introduction
Browse ICD-10-PCS procedures starting with prefix XW0.
Definition
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
New Technology, Anatomical Regions, Introduction, Skin, External, Anacaulase-bcdb, New Technology Group 7
XW01318New Technology, Anatomical Regions, Introduction, Subcutaneous Tissue, Percutaneous, Daratumumab and Hyaluronidase-fihj, New Technology Group 8
XW01329New Technology, Anatomical Regions, Introduction, Subcutaneous Tissue, Percutaneous, Talquetamab Antineoplastic, New Technology Group 9
XW01348New Technology, Anatomical Regions, Introduction, Subcutaneous Tissue, Percutaneous, Teclistamab Antineoplastic, New Technology Group 8
XW0136ANew Technology, Anatomical Regions, Introduction, Subcutaneous Tissue, Percutaneous, Dasiglucagon, New Technology Group 10
XW01397New Technology, Anatomical Regions, Introduction, Subcutaneous Tissue, Percutaneous, Satralizumab-mwge, New Technology Group 7
XW013F5New Technology, Anatomical Regions, Introduction, Subcutaneous Tissue, Percutaneous, Other New Technology Therapeutic Substance, New Technology Group 5
XW013G6New Technology, Anatomical Regions, Introduction, Subcutaneous Tissue, Percutaneous, REGN-COV2 Monoclonal Antibody, New Technology Group 6
XW013H6New Technology, Anatomical Regions, Introduction, Subcutaneous Tissue, Percutaneous, Other New Technology Monoclonal Antibody, New Technology Group 6
XW013K6New Technology, Anatomical Regions, Introduction, Subcutaneous Tissue, Percutaneous, Leronlimab Monoclonal Antibody, New Technology Group 6
XW013L9New Technology, Anatomical Regions, Introduction, Subcutaneous Tissue, Percutaneous, Elranatamab Antineoplastic, New Technology Group 9
XW013S6New Technology, Anatomical Regions, Introduction, Subcutaneous Tissue, Percutaneous, COVID-19 Vaccine Dose 1, New Technology Group 6
XW013S9New Technology, Anatomical Regions, Introduction, Subcutaneous Tissue, Percutaneous, Epcoritamab Monoclonal Antibody, New Technology Group 9
XW013T6New Technology, Anatomical Regions, Introduction, Subcutaneous Tissue, Percutaneous, COVID-19 Vaccine Dose 2, New Technology Group 6
XW013TBNew Technology, Anatomical Regions, Introduction, Subcutaneous Tissue, Percutaneous, Rozanolixizumab-noli Monoclonal Antibody, New Technology Group 11
XW013U6New Technology, Anatomical Regions, Introduction, Subcutaneous Tissue, Percutaneous, COVID-19 Vaccine, New Technology Group 6
XW013V7New Technology, Anatomical Regions, Introduction, Subcutaneous Tissue, Percutaneous, COVID-19 Vaccine Dose 3, New Technology Group 7
XW013W5New Technology, Anatomical Regions, Introduction, Subcutaneous Tissue, Percutaneous, Caplacizumab, New Technology Group 5
XW013W7New Technology, Anatomical Regions, Introduction, Subcutaneous Tissue, Percutaneous, COVID-19 Vaccine Booster, New Technology Group 7
XW01X27New Technology, Anatomical Regions, Introduction, Subcutaneous Tissue, External, Anacaulase-bcdb, New Technology Group 7
XW020D8New Technology, Anatomical Regions, Introduction, Muscle, Open, Engineered Allogeneic Thymus Tissue, New Technology Group 8
XW023S6New Technology, Anatomical Regions, Introduction, Muscle, Percutaneous, COVID-19 Vaccine Dose 1, New Technology Group 6
XW023T6New Technology, Anatomical Regions, Introduction, Muscle, Percutaneous, COVID-19 Vaccine Dose 2, New Technology Group 6
XW023U6New Technology, Anatomical Regions, Introduction, Muscle, Percutaneous, COVID-19 Vaccine, New Technology Group 6
XW023V7New Technology, Anatomical Regions, Introduction, Muscle, Percutaneous, COVID-19 Vaccine Dose 3, New Technology Group 7
XW023W7New Technology, Anatomical Regions, Introduction, Muscle, Percutaneous, COVID-19 Vaccine Booster, New Technology Group 7
XW023X7New Technology, Anatomical Regions, Introduction, Muscle, Percutaneous, Tixagevimab and Cilgavimab Monoclonal Antibody, New Technology Group 7
XW023Y7New Technology, Anatomical Regions, Introduction, Muscle, Percutaneous, Other New Technology Monoclonal Antibody, New Technology Group 7
XW03308New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Spesolimab Monoclonal Antibody, New Technology Group 8
XW0330BNew Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Alpha1-proteinase Inhibitor, New Technology Group 11
XW0331BNew Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Anitocabtagene Autoleucel Immunotherapy, New Technology Group 11
XW0333ANew Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Bentracimab, Ticagrelor Reversal Agent, New Technology Group 10
XW0334ANew Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Cefepime-taniborbactam Anti-infective, New Technology Group 10
XW03357New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Narsoplimab Monoclonal Antibody, New Technology Group 7
XW03358New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Mosunetuzumab Antineoplastic, New Technology Group 8
XW0335ANew Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Ceftobiprole Medocaril Anti-infective, New Technology Group 10
XW03367New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Terlipressin, New Technology Group 7
XW03368New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Afamitresgene Autoleucel Immunotherapy, New Technology Group 8
XW03372New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Coagulation Factor Xa, Inactivated, New Technology Group 2
XW03377New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Trilaciclib, New Technology Group 7
XW03378New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Tabelecleucel Immunotherapy, New Technology Group 8
XW03387New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Lurbinectedin, New Technology Group 7
XW03388New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Treosulfan, New Technology Group 8
XW0338ANew Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Obecabtagene Autoleucel, New Technology Group 10
XW03396New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Ceftolozane/Tazobactam Anti-infective, New Technology Group 6
XW03398New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Inebilizumab-cdon, New Technology Group 8
XW0339ANew Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Odronextamab Antineoplastic, New Technology Group 10
XW033A7New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Ciltacabtagene Autoleucel, New Technology Group 7
XW033B3New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Cytarabine and Daunorubicin Liposome Antineoplastic, New Technology Group 3
XW033B7New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Amivantamab Monoclonal Antibody, New Technology Group 7
XW033BANew Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Orca-T Allogeneic T-cell Immunotherapy, New Technology Group 10
XW033C7New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous, New Technology Group 7
XW033CANew Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Zanidatamab Antineoplastic, New Technology Group 10
XW033DANew Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Donislecel-jujn Allogeneic Pancreatic Islet Cellular Suspension, New Technology Group 10
XW033E5New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Remdesivir Anti-infective, New Technology Group 5
XW033F3New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Other New Technology Therapeutic Substance, New Technology Group 3
XW033F5New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Other New Technology Therapeutic Substance, New Technology Group 5
XW033FANew Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Non-Chimeric Antigen Receptor T-cell Immune Effector Cell Therapy, New Technology Group 10
XW033FBNew Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Valoctocogene Roxaparvovec-rvox, New Technology Group 11
XW033G5New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Sarilumab, New Technology Group 5
XW033G6New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, REGN-COV2 Monoclonal Antibody, New Technology Group 6
XW033G7New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic, New Technology Group 7
XW033H5New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Tocilizumab, New Technology Group 5
XW033H6New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Other New Technology Monoclonal Antibody, New Technology Group 6
XW033H7New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Axicabtagene Ciloleucel Immunotherapy, New Technology Group 7
XW033J7New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Tisagenlecleucel Immunotherapy, New Technology Group 7
XW033K7New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Idecabtagene Vicleucel Immunotherapy, New Technology Group 7
XW033K9New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Sulbactam-Durlobactam, New Technology Group 9
XW033L6New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, CD24Fc Immunomodulator, New Technology Group 6
XW033L7New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Lifileucel Immunotherapy, New Technology Group 7
XW033M7New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Brexucabtagene Autoleucel Immunotherapy, New Technology Group 7
XW033MANew Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Emapalumab-lzsg Anti-IFNy Monoclonal Antibody, New Technology Group 10
XW033N7New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Lisocabtagene Maraleucel Immunotherapy, New Technology Group 7
XW033NANew Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Tarlatamab-dlle Antineoplastic, New Technology Group 10
XW033P9New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Glofitamab Antineoplastic, New Technology Group 9
XW033PBNew Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Aztreonam-avibactam Anti-infective, New Technology Group 11
XW033Q5New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Tagraxofusp-erzs Antineoplastic, New Technology Group 5
XW033Q9New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Posoleucel, New Technology Group 9
XW033QBNew Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Iloprost, New Technology Group 11
XW033R9New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Rezafungin, New Technology Group 9
XW033RBNew Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Letetresgene Autoleucel, New Technology Group 11
XW033S5New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Iobenguane I-131 Antineoplastic, New Technology Group 5
XW033W5New Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Caplacizumab, New Technology Group 5
XW033WBNew Technology, Anatomical Regions, Introduction, Peripheral Vein, Percutaneous, Fosfomycin Anti-infective, New Technology Group 11
XW04308New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Spesolimab Monoclonal Antibody, New Technology Group 8
XW0430BNew Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Alpha1-proteinase Inhibitor, New Technology Group 11
XW0431BNew Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Anitocabtagene Autoleucel Immunotherapy, New Technology Group 11
XW0433ANew Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Bentracimab, Ticagrelor Reversal Agent, New Technology Group 10
XW0434ANew Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Cefepime-taniborbactam Anti-infective, New Technology Group 10
XW04357New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Narsoplimab Monoclonal Antibody, New Technology Group 7
XW04358New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Mosunetuzumab Antineoplastic, New Technology Group 8
XW0435ANew Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Ceftobiprole Medocaril Anti-infective, New Technology Group 10
XW04367New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Terlipressin, New Technology Group 7
XW04368New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Afamitresgene Autoleucel Immunotherapy, New Technology Group 8
XW04372New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Coagulation Factor Xa, Inactivated, New Technology Group 2
XW04377New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Trilaciclib, New Technology Group 7
XW04378New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Tabelecleucel Immunotherapy, New Technology Group 8
XW04387New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Lurbinectedin, New Technology Group 7
XW04388New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Treosulfan, New Technology Group 8
XW0438ANew Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Obecabtagene Autoleucel, New Technology Group 10
XW04396New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Ceftolozane/Tazobactam Anti-infective, New Technology Group 6
XW04398New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Inebilizumab-cdon, New Technology Group 8
XW0439ANew Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Odronextamab Antineoplastic, New Technology Group 10
XW043A7New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Ciltacabtagene Autoleucel, New Technology Group 7
XW043B3New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Cytarabine and Daunorubicin Liposome Antineoplastic, New Technology Group 3
XW043B7New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Amivantamab Monoclonal Antibody, New Technology Group 7
XW043BANew Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Orca-T Allogeneic T-cell Immunotherapy, New Technology Group 10
XW043C7New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous, New Technology Group 7
XW043CANew Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Zanidatamab Antineoplastic, New Technology Group 10
XW043E5New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Remdesivir Anti-infective, New Technology Group 5
XW043F3New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Other New Technology Therapeutic Substance, New Technology Group 3
XW043F5New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Other New Technology Therapeutic Substance, New Technology Group 5
XW043FANew Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Non-Chimeric Antigen Receptor T-cell Immune Effector Cell Therapy, New Technology Group 10
XW043FBNew Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Valoctocogene Roxaparvovec-rvox, New Technology Group 11
XW043G5New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Sarilumab, New Technology Group 5
XW043G6New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, REGN-COV2 Monoclonal Antibody, New Technology Group 6
XW043G7New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic, New Technology Group 7
XW043H5New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Tocilizumab, New Technology Group 5
XW043H6New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Other New Technology Monoclonal Antibody, New Technology Group 6
XW043H7New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Axicabtagene Ciloleucel Immunotherapy, New Technology Group 7
XW043J7New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Tisagenlecleucel Immunotherapy, New Technology Group 7
XW043K7New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Idecabtagene Vicleucel Immunotherapy, New Technology Group 7
XW043K9New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Sulbactam-Durlobactam, New Technology Group 9
XW043L6New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, CD24Fc Immunomodulator, New Technology Group 6
XW043L7New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Lifileucel Immunotherapy, New Technology Group 7
XW043M7New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Brexucabtagene Autoleucel Immunotherapy, New Technology Group 7
XW043MANew Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Emapalumab-lzsg Anti-IFNy Monoclonal Antibody, New Technology Group 10
XW043N7New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Lisocabtagene Maraleucel Immunotherapy, New Technology Group 7
XW043NANew Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Tarlatamab-dlle Antineoplastic, New Technology Group 10
XW043P9New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Glofitamab Antineoplastic, New Technology Group 9
XW043PBNew Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Aztreonam-avibactam Anti-infective, New Technology Group 11
XW043Q5New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Tagraxofusp-erzs Antineoplastic, New Technology Group 5
XW043Q9New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Posoleucel, New Technology Group 9
XW043QBNew Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Iloprost, New Technology Group 11
XW043R9New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Rezafungin, New Technology Group 9
XW043RBNew Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Letetresgene Autoleucel, New Technology Group 11
XW043S5New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Iobenguane I-131 Antineoplastic, New Technology Group 5
XW043W5New Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Caplacizumab, New Technology Group 5
XW043WBNew Technology, Anatomical Regions, Introduction, Central Vein, Percutaneous, Fosfomycin Anti-infective, New Technology Group 11
XW0534BNew Technology, Anatomical Regions, Introduction, Peripheral Artery, Percutaneous, Stem Cells, Somatic, New Technology Group 11
XW053T9New Technology, Anatomical Regions, Introduction, Peripheral Artery, Percutaneous, Melphalan Hydrochloride Antineoplastic, New Technology Group 9
XW0632BNew Technology, Anatomical Regions, Introduction, Cerebral Ventricle, Percutaneous, CPI-601 Enzyme Replacement Therapy, New Technology Group 11
XW0DX38New Technology, Anatomical Regions, Introduction, Mouth and Pharynx, External, Maribavir Anti-infective, New Technology Group 8
XW0DX82New Technology, Anatomical Regions, Introduction, Mouth and Pharynx, External, Uridine Triacetate, New Technology Group 2
XW0DXF5New Technology, Anatomical Regions, Introduction, Mouth and Pharynx, External, Other New Technology Therapeutic Substance, New Technology Group 5
XW0DXJ9New Technology, Anatomical Regions, Introduction, Mouth and Pharynx, External, Quizartinib Antineoplastic, New Technology Group 9
XW0DXK8New Technology, Anatomical Regions, Introduction, Mouth and Pharynx, External, Sabizabulin, New Technology Group 8
XW0DXM6New Technology, Anatomical Regions, Introduction, Mouth and Pharynx, External, Baricitinib, New Technology Group 6
XW0DXN9New Technology, Anatomical Regions, Introduction, Mouth and Pharynx, External, SER-109, New Technology Group 9
XW0DXR7New Technology, Anatomical Regions, Introduction, Mouth and Pharynx, External, Fostamatinib, New Technology Group 7
XW0DXVBNew Technology, Anatomical Regions, Introduction, Mouth and Pharynx, External, Xanomeline and Trospium Chloride, New Technology Group 11
XW0E33BNew Technology, Anatomical Regions, Introduction, Ear(s), Percutaneous, DB-OTO via Intracochlear Infusion, New Technology Group 11
XW0G738New Technology, Anatomical Regions, Introduction, Upper GI, Via Natural or Artificial Opening, Maribavir Anti-infective, New Technology Group 8
XW0G7K8New Technology, Anatomical Regions, Introduction, Upper GI, Via Natural or Artificial Opening, Sabizabulin, New Technology Group 8
XW0G7M6New Technology, Anatomical Regions, Introduction, Upper GI, Via Natural or Artificial Opening, Baricitinib, New Technology Group 6
XW0G7R7New Technology, Anatomical Regions, Introduction, Upper GI, Via Natural or Artificial Opening, Fostamatinib, New Technology Group 7
XW0G886New Technology, Anatomical Regions, Introduction, Upper GI, Via Natural or Artificial Opening Endoscopic, Mineral-based Topical Hemostatic Agent, New Technology Group 6
XW0H738New Technology, Anatomical Regions, Introduction, Lower GI, Via Natural or Artificial Opening, Maribavir Anti-infective, New Technology Group 8
XW0H7K8New Technology, Anatomical Regions, Introduction, Lower GI, Via Natural or Artificial Opening, Sabizabulin, New Technology Group 8
XW0H7M6New Technology, Anatomical Regions, Introduction, Lower GI, Via Natural or Artificial Opening, Baricitinib, New Technology Group 6
XW0H7R7New Technology, Anatomical Regions, Introduction, Lower GI, Via Natural or Artificial Opening, Fostamatinib, New Technology Group 7
XW0H7X8New Technology, Anatomical Regions, Introduction, Lower GI, Via Natural or Artificial Opening, Broad Consortium Microbiota-based Live Biotherapeutic Suspension, New Technology Group 8
XW0H886New Technology, Anatomical Regions, Introduction, Lower GI, Via Natural or Artificial Opening Endoscopic, Mineral-based Topical Hemostatic Agent, New Technology Group 6
XW0J3HANew Technology, Anatomical Regions, Introduction, Coronary Artery, One Artery, Percutaneous, Paclitaxel-Coated Balloon Technology, One Balloon, New Technology Group 10
XW0J3JANew Technology, Anatomical Regions, Introduction, Coronary Artery, One Artery, Percutaneous, Paclitaxel-Coated Balloon Technology, Two Balloons, New Technology Group 10
XW0J3KANew Technology, Anatomical Regions, Introduction, Coronary Artery, One Artery, Percutaneous, Paclitaxel-Coated Balloon Technology, Three Balloons, New Technology Group 10
XW0J3LANew Technology, Anatomical Regions, Introduction, Coronary Artery, One Artery, Percutaneous, Paclitaxel-Coated Balloon Technology, Four or More Balloons, New Technology Group 10
XW0K3HANew Technology, Anatomical Regions, Introduction, Coronary Artery, Two Arteries, Percutaneous, Paclitaxel-Coated Balloon Technology, One Balloon, New Technology Group 10
XW0K3JANew Technology, Anatomical Regions, Introduction, Coronary Artery, Two Arteries, Percutaneous, Paclitaxel-Coated Balloon Technology, Two Balloons, New Technology Group 10
XW0K3KANew Technology, Anatomical Regions, Introduction, Coronary Artery, Two Arteries, Percutaneous, Paclitaxel-Coated Balloon Technology, Three Balloons, New Technology Group 10
XW0K3LANew Technology, Anatomical Regions, Introduction, Coronary Artery, Two Arteries, Percutaneous, Paclitaxel-Coated Balloon Technology, Four or More Balloons, New Technology Group 10
XW0L3HANew Technology, Anatomical Regions, Introduction, Coronary Artery, Three Arteries, Percutaneous, Paclitaxel-Coated Balloon Technology, One Balloon, New Technology Group 10
XW0L3JANew Technology, Anatomical Regions, Introduction, Coronary Artery, Three Arteries, Percutaneous, Paclitaxel-Coated Balloon Technology, Two Balloons, New Technology Group 10
XW0L3KANew Technology, Anatomical Regions, Introduction, Coronary Artery, Three Arteries, Percutaneous, Paclitaxel-Coated Balloon Technology, Three Balloons, New Technology Group 10
XW0L3LANew Technology, Anatomical Regions, Introduction, Coronary Artery, Three Arteries, Percutaneous, Paclitaxel-Coated Balloon Technology, Four or More Balloons, New Technology Group 10
XW0M3HANew Technology, Anatomical Regions, Introduction, Coronary Artery, Four or More Arteries, Percutaneous, Paclitaxel-Coated Balloon Technology, One Balloon, New Technology Group 10
XW0M3JANew Technology, Anatomical Regions, Introduction, Coronary Artery, Four or More Arteries, Percutaneous, Paclitaxel-Coated Balloon Technology, Two Balloons, New Technology Group 10
XW0M3KANew Technology, Anatomical Regions, Introduction, Coronary Artery, Four or More Arteries, Percutaneous, Paclitaxel-Coated Balloon Technology, Three Balloons, New Technology Group 10
XW0M3LANew Technology, Anatomical Regions, Introduction, Coronary Artery, Four or More Arteries, Percutaneous, Paclitaxel-Coated Balloon Technology, Four or More Balloons, New Technology Group 10
XW0Q316New Technology, Anatomical Regions, Introduction, Cranial Cavity and Brain, Percutaneous, Eladocagene exuparvovec, New Technology Group 6
XW0U0GANew Technology, Anatomical Regions, Introduction, Joints, Open, Vancomycin Hydrochloride and Tobramycin Sulfate Anti-Infective, Temporary Irrigation Spacer System, New Technology Group 10
XW0U0XBNew Technology, Anatomical Regions, Introduction, Joints, Open, Peptide Enhanced Bone Void Filler, New Technology Group 11
XW0U3XBNew Technology, Anatomical Regions, Introduction, Joints, Percutaneous, Peptide Enhanced Bone Void Filler, New Technology Group 11
XW0U4XBNew Technology, Anatomical Regions, Introduction, Joints, Percutaneous Endoscopic, Peptide Enhanced Bone Void Filler, New Technology Group 11
XW0V0P7New Technology, Anatomical Regions, Introduction, Bones, Open, Antibiotic-eluting Bone Void Filler, New Technology Group 7
XW0V3WANew Technology, Anatomical Regions, Introduction, Bones, Percutaneous, AGN1 Bone Void Filler, New Technology Group 10
Need OPPS payment calculations?
Bedrock Billing prices outpatient claims with HCPCS, APC, and status indicator logic built in.
Try Bedrock Billing for Free